Evropska unija - estonščina - EMA (European Medicines Agency)

biogen netherlands b.v. - diroximel fumarate (biib098) - sclerosis multiplex, relapsing-remitting - immunosupressandid - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

Evropska unija - estonščina - EMA (European Medicines Agency)

mylan ireland limited - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Evropska unija - estonščina - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Estonija - estonščina - Ravimiamet

sandoz pharmaceuticals d.d. - dimetüülfumaraat - gastroresistentne kõvakapsel - 120mg 14tk

Estonija - estonščina - Ravimiamet

sandoz pharmaceuticals d.d. - dimetüülfumaraat - gastroresistentne kõvakapsel - 240mg 56tk

Evropska unija - estonščina - EMA (European Medicines Agency)

teva gmbh - dimetüülfumaraat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosupressandid - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Evropska unija - estonščina - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimetüülfumaraat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosupressandid - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Estonija - estonščina - Ravimiamet

sandoz pharmaceuticals d.d. - dimetüülfumaraat - gastroresistentne kõvakapsel - 120mg 14tk

Estonija - estonščina - Ravimiamet

sandoz pharmaceuticals d.d. - dimetüülfumaraat - gastroresistentne kõvakapsel - 240mg 196tk; 240mg 56tk; 240mg 100tk; 240mg 168tk

Evropska unija - estonščina - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - elotuzumab - mitu müeloomit - antineoplastilised ained - empliciti on näidustatud kombinatsioonis lenalidomide ja deksametasooni raviks hulgimüeloom täiskasvanud patsientidel, kes on saanud vähemalt ühe eelneva ravi (vt lõigud 4. 2 ja 5.